University of Southern California and the Cleveland Clinic Florida Research and Innovation Center researchers have published new research on GRP78, a protein implicated in both COVID-19.

First identified in 2019 in Wuhan, China, COVID-19, or Coronavirus disease 2019, (which was originally called “2019 novel coronavirus” or 2019-nCoV) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has spread globally, resulting in the 2019–22 coronavirus pandemic.

The innovation was inspired by the measles virus.

In a world-first, researchers at Tel Aviv University have conceived of a way to control the encapsulation and release of drug molecules by exposure to UV light, according to a press release by the institution published on Monday.

The scientists now hope that this new efficient encapsulation will allow for the high loading capacity of molecules leading to further development of delivery systems for the controlled release of biomolecules and drugs in the body by external stimuli using light.

Researchers have discovered that salen can effectively bind a number of proteins of the coronavirus SARS-CoV-2.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the official name of the virus strain that causes coronavirus disease (COVID-19). Previous to this name being adopted, it was commonly referred to as the 2019 novel coronavirus (2019-nCoV), the Wuhan coronavirus, or the Wuhan virus.